Mach7 Technologies Limited

OTC: TDMMF · Healthcare · Medical - Healthcare Information Services

PublicHQ South Burlington, VT · ChittendenReports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 61

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, workforce scale · ↓ listing tenure, market scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

296

as of 2026-08-19

Market cap

$47.0M

as of 2026-08-19

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue—33.8M AUD2025

Net income—-6.2M AUD2025

Operating income—612.8k AUD2025

Total assets—64.2M AUD2025

Liabilities—18.6M AUD2025

Equity—45.6M AUD2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Mach7 Technologies Limited’s financial profile?

Mach7 Technologies Limited has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

MiNK Therapeutics, Inc.——BioStem Technologies, Inc.——Apollomics, Inc.——Vicapsys Life Sciences, Inc.——Context Therapeutics Inc.——Cell Source, Inc.——

Neighbors

Chittenden →

BETA Technologies, Inc.$35.6M23D

Key facts

CEOTeri Thomas

SectorHealthcare

IndustryMedical - Healthcare Information Services

HeadquartersSouth Burlington, VT

ExchangeOTC: TDMMF

Employees296

IPO date2015-12-31

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.